Stelara (Ustekinumab) Versus Etanercept for Psoriasis

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2010年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：572 / 572
页数：1
相关论文
共 50 条
  • [1] Ustekinumab (Stelara) for Psoriasis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1330): : 7 - 8
  • [2] Information letter on treatment of psoriasis with ustekinumab (Stelara®)
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 (12): : 874 - 875
  • [3] PSORIASIS Is ustekinumab superior to etanercept for psoriasis?
    Kuhn, Annegret
    Luger, Thomas A.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (09) : 500 - 501
  • [4] Is ustekinumab superior to etanercept for psoriasis?
    Annegret Kuhn
    Thomas A. Luger
    Nature Reviews Rheumatology, 2010, 6 : 500 - 501
  • [5] Stelara™ (ustekinumab)
    Halpern, Analisa V.
    Peikin, Steven R.
    Ferzli, Pascal
    Heymann, Warren R.
    CUTIS, 2009, 84 (06): : 301 - 304
  • [6] The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients
    Young, Melodie S.
    Horn, Elizabeth J.
    Cather, Jennifer C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (01) : 9 - 13
  • [7] Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis
    Uhlenhake, Elizabeth E.
    Feldman, Steven R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (07) : 1105 - 1112
  • [8] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
  • [9] Cost per responder of apremilast versus etanercept, adalimumab, and ustekinumab in patients with moderate to severe psoriasis
    Feldman, Steven R.
    Tencer, Tom
    Clancy, Zoe
    Zhang, Frank
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB229 - AB229
  • [10] COST-EFFECTIVENESS OF USTEKINUMAB VERSUS ETANERCEPT IN SEVERE PLAQUE PSORIASIS PATIENTS: A CANADIAN PERSPECTIVE
    Brazier, N.
    Pan, F.
    Shear, N.
    Jivraj, F.
    Schenkel, B.
    Brown, R.
    VALUE IN HEALTH, 2009, 12 (07) : A457 - A457
12345